Previous 10 | Next 10 |
In a statement , FDA Commissioner Scott Gottlieb, M.D. says the agency has submitted its request for $6.1B in funding for fiscal 2020, an increase of $643M from this fiscal year. More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Trust, Tekla ...
Effective in June, Health Canada will institute new regulations related to the marketing of Class B opioids, a class of painkillers equal to or stronger than morphine. More news on: Endo International plc, INSYS Therapeutics, Inc., Titan Pharmaceuticals, Inc., Healthcare stocks news, ...
Insys Therapeutics (NASDAQ: INSY ): Q4 Non-GAAP EPS of -$0.37 misses by $0.08 ; GAAP EPS of -$0.62 misses by $0.29 . Revenue of $16.36M (-48.0% Y/Y) misses by $1.72M . Shares -1.4% . Press Release More news on: Insys Therapeutics, Inc., Earnings news and commentary, Healthcare ...
PHOENIX, March 07, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reported financial results for its fourth quarter and full year ended Dec. 31, 2018....
PHOENIX, March 06, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced that it will release its fourth quarter and full year 2018 financial resul...
HENDERSON, NV / ACCESSWIRE / March 6, 2019 / OxyContin maker Purdue Pharma is exploring filing for bankruptcy as one of its options to address potentially significant liabilities from thousands of lawsuits alleging the drug maker contributed to the deadly opioid crisis sweeping the U.S. This...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on winning breakout selections over more than 5 years including 94 weeks of public weekly selections as part of this ongoing live forward-testing. Breakout Stock Portfolio 2019 results YTD All time total...
CORAL GABLES, FL / ACCESSWIRE / February 27, 2019 / The marijuana stock market has come quite a long way over the course of the past few years. Generations upon generations have disregarded cannabis and its associated companies because the federal government held it to the same status as m...
CORAL GABLES, FL / ACCESSWIRE / February 25, 2019 / Perhaps what is most interest about marijuana stocks is how, despite years of condemnation and uncertainty, companies invested in the cannabis sector have managed to thrive. Over the course of the last several years, the marijuana industr...
Results from an early-stage study assessing the pharmacokinetics of INSYS Therapeutics' ( INSY +0.5% ) epinephrine nasal spray in adults with seasonal allergies showed rapid absorption for both formulations tested. The data were presented at the American Academy of Allergy, Asthma and I...
News, Short Squeeze, Breakout and More Instantly...
Insys Therapeutics Inc. Company Name:
INSY Stock Symbol:
NASDAQ Market:
Insys Therapeutics Inc. Website:
GD Entertainment and Technology’s (OTC: GDET ) Anil Idnani, CEO, will discuss the company’s 2020 outlook when he is interviewed by Stock Market Podcast. He will focus on GDET’s new customizable, prepaid ‘Dream Card’ and also the marketing of its CBD produc...
GD Entertainment and Technology (OTC: GDET ) announces today (June 15, 2020) that Anil Idnani, CEO,will be interviewed by Stock Market Podcast and offer a review of the company’s marketing growth and 2020 outlook. The company is focusing on both its re-introduced customizable, ...
Reinforcing the strength of CBD sales, website 420 Intel reported that sales of CBD hit $103 million for the month of May — the state’s first $100 million-plus month — representing a 15% jump over April and a 60% YOY spike from May last year. It was the third straight mo...